These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 157972)

  • 41. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
    Cong L; Wang SF; Zhao ZL; Yang RY
    Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A preliminary study on the mechanism of neonatal allotransplantation tolerance. Participation of suppressor cells in the mediation of neonatal allotransplantation tolerance.
    Jiang H; Shi MY; Yao LR
    Sci Sin B; 1985 Apr; 28(4):365-72. PubMed ID: 3160109
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro demonstration of suppression of the efferent site in transplantation immunity with antilymphocyte serum.
    Tadakuma T; Watanabe S; Mitsuma T; Saito K
    Jpn J Microbiol; 1971 Jan; 15(1):105-8. PubMed ID: 4927837
    [No Abstract]   [Full Text] [Related]  

  • 44. ACQUIRED TOLERANCE TO SKIN HOMOGRAFTS IN MICE. 3. ROLE OF IMMUNE STATUS OF HOST IN INDUCTION AND MAINTENANCE OF TOLERANCE.
    ARGYRIS BF
    J Immunol; 1964 Jul; 93():114-21. PubMed ID: 14214374
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of cell membranes with and without antilymphocyte serum on skin and heart allograft survival.
    Matolo NM; Reemtsma K; Dewitt CW
    Transplantation; 1972 Mar; 13(3):265-9. PubMed ID: 4553728
    [No Abstract]   [Full Text] [Related]  

  • 46. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice.
    Ohzato H; Monaco AP
    Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heterogeneity of tolerance to xenogenic cells in mice inoculated at birth with rat cells.
    Chutná J; Holán V; Hasek M
    Cell Immunol; 1981 Sep; 63(1):193-7. PubMed ID: 6456074
    [No Abstract]   [Full Text] [Related]  

  • 48. Prolongation of skin allograft survival with spleen extracts and antilymphocytic serum.
    Brent L; Kilshaw PJ
    Nature; 1970 Aug; 227(5261):898-900. PubMed ID: 4915404
    [No Abstract]   [Full Text] [Related]  

  • 49. Prolonged administration of antithymocyte serum in mice. I. Observations on cellular and humoral immunity.
    Nehlsen SL
    Clin Exp Immunol; 1971 Jul; 9(1):63-77. PubMed ID: 4397709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Enhancement phenomenon in mice with a heterotopic heart transplant].
    Frolova MA; Gudkova RG; Bol'shukhina LA; Novoselova VN
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Oct; (10):36-40. PubMed ID: 85397
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 52. Acceleration of graft rejection by pretreatment of the graft donor with recipient cells (donor sensitization).
    Harris NS; Van Alten PJ
    Cell Immunol; 1974 Mar; 11(1-3):342-53. PubMed ID: 4616764
    [No Abstract]   [Full Text] [Related]  

  • 53. Marked prolongation of skin homograft survival with niridazole. A first report.
    Mandel MA; Mahmoud AA; Warren KS
    Plast Reconstr Surg; 1975 Jan; 55(1):76-89. PubMed ID: 1089984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of rosette formation by spleen cells from grafted mice treated with anti-lymphocyte serum.
    Mosedale B; Parke JA
    Transplantation; 1970 Oct; 10(4):347-9. PubMed ID: 4927390
    [No Abstract]   [Full Text] [Related]  

  • 55. Generation of suppressor cells maintains donor-specific tolerance after intrathymic injection of alloantigen.
    Nakafusa Y; Arima T; Goss JA; Flye MW
    Transplant Proc; 1995 Feb; 27(1):128-9. PubMed ID: 7878881
    [No Abstract]   [Full Text] [Related]  

  • 56. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bm1 cardiac grafts.
    Mohiuddin M; Ruggiero V; Shen Z; DiSesa VJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):310-3. PubMed ID: 8751496
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antithymocyte globulin (ATG) and trenimon (TR): effects on T cells and graft rejection.
    Beatty JD; Friesen E; Linford JH; Israels LG
    Surg Forum; 1977; 28():327-9. PubMed ID: 364726
    [No Abstract]   [Full Text] [Related]  

  • 58. Evidence for local helper and suppressor function at the site of allograft rejection.
    Ascher NL; Hoffman R; Chen S; Simmons RL
    Surgery; 1980 Aug; 88(2):274-80. PubMed ID: 6446779
    [No Abstract]   [Full Text] [Related]  

  • 59. T cell-derived factor alone or in combination with immunosuppressive drugs augments prolongation of allogeneic skin graft survival in mice receiving donor-specific transfusion.
    Gorczynski RM; Boulanger M; Lau C
    J Immunol; 1987 May; 138(10):3197-202. PubMed ID: 2952712
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms maintaining enhancement of allografts. I. Demonstration of a specific suppressor cell.
    Hall BM
    J Exp Med; 1985 Jan; 161(1):123-33. PubMed ID: 3155790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.